Home/Filings/4/0001104659-22-012788
4//SEC Filing

MANNING MARTHA E 4

Accession 0001104659-22-012788

CIK 0001267813other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:11 PM ET

Size

16.2 KB

Accession

0001104659-22-012788

Insider Transaction Report

Form 4
Period: 2022-02-04
MANNING MARTHA E
SVP, GEN. COUNSEL & CORP. SEC.
Transactions
  • Award

    Common Stock

    2022-02-04+12,86712,867 total
  • Award

    Stock Option (Right to Buy)

    2022-02-04+57,90057,900 total
    Exercise: $10.40Exp: 2032-02-04Common Stock (57,900 underlying)
Footnotes (2)
  • [F1]Represents the grant of restricted stock units (RSUs). The RSUs vest in three equal installments, with the first installment vesting on August 4, 2023, the second installment vesting on August 4, 2024, and the third installment vesting on August 4, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
  • [F2]The option vests and becomes exercisable in 36 equal monthly installments beginning on March 4, 2022.

Issuer

MARINUS PHARMACEUTICALS INC

CIK 0001267813

Entity typeother

Related Parties

1
  • filerCIK 0001227894

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:11 PM ET
Size
16.2 KB